Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Anaptysbio, Inc.

Clinical trials sponsored by Anaptysbio, Inc., explained in plain language.

AnaptysBio ANAB NASDAQ

A clinical-stage biotechnology company developing immunology therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1

New drug rosnilimab aims to tame ulcerative colitis in Mid-Stage trial

Disease control Ongoing

This study tests a new drug called rosnilimab in 132 adults with moderate to severe ulcerative colitis. The goal is to see if it can reduce disease activity and improve symptoms compared to a placebo. Participants must have tried other treatments without success. The trial is act…

Phase: PHASE2 • Sponsor: AnaptysBio, Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:53 UTC